F/M Investments’s Amgen AMGN Stock Holding History

F/M Investments’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Sell	4,809 -11	-0.2%	-$3.77K	0.09%	128
2026 Q1	$1.7M	Sell	4,820 -12,472	-72%	-$4.45M	0.11%	116
2025 Q4	$5.66M	Sell	17,292 -1	-0%	-$317	0.22%	114
2025 Q3	$4.88M	Sell	17,293 -228	-1%	-$66.1K	0.19%	130
2025 Q2	$4.89M	Buy	17,521 +358	+2%	+$101K	0.18%	121
2025 Q1	$5.35M	Sell	17,163 -248	-1%	-$73.2K	0.21%	93
2024 Q4	$4.54M	Buy	17,411 +3,818	+28%	+$1.13M	0.17%	125
2024 Q3	$6.83M	Sell	13,593 -1,163	-8%	-$380K	0.21%	148
2024 Q2	$4.61M	Buy	+14,756	New	+$4.34M	0.17%	163
2021 Q2	–	Sell	-1,287	Closed	-$320K	–	67
2021 Q1	$320K	Buy	1,287 +392	+44%	+$93.5K	0.25%	55
2020 Q4	$206K	Buy	+895	New	+$206K	0.18%	58

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

F/M Investments's AMGN Position: Q2 2026 in Review

F/M Investments reduced its Amgen (AMGN) stake by 0.23% in Q2 2026, selling an estimated $3.77K and leaving 4,809 shares worth $1.74M. The position accounts for 0.09% of the portfolio, ranked #128.

F/M Investments first reported a position in AMGN in Q4 2020 and has held it in 11 quarters since. The position peaked at $6.83M in Q3 2024. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

F/M Investments held 4,809 shares of Amgen worth $1.74M as of Q2 2026.
F/M Investments sold 11 Amgen shares in Q2 2026, an estimated $3.77K.
Amgen made up 0.09% of F/M Investments's portfolio in Q2 2026, its #128 holding.
F/M Investments first reported a position in Amgen in Q4 2020 and has held it in 11 quarters since.
F/M Investments's Amgen position peaked at $6.83M in Q3 2024.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.